Don't Try This At Home: Zazzle-Created EstroGel Promo Card Fizzles With FDA
This article was originally published in The Pink Sheet Daily
Low-grade sales piece touting cost savings with Ascend Therapeutics’ product lacks risk information; it is just the seventh Rx citation by FDA this year.
You may also be interested in...
Professional sell sheet falsely suggests estradiol gel contains lowest effective dose of estrogen compared to other estrogen products, OPDP says in fourth “untitled” letter of 2018.
Ascend Therapeutics aims to develop two non-hormone drugs delivered via hydroalcoholic gels that penetrate quickly into the skin.
The US FDA reports that the prescription drug user fee program met 27 of its 29 commitments by the end of FY 2021 and the biosimilar user fee program is on track to meet 16 of 27 of its performance enhancement goals.